# Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures

> **NCT02580227** · PHASE4 · UNKNOWN · sponsor: **Good Samaritan Regional Medical Center, Oregon** · enrollment: 100 (estimated)

## Conditions studied

- Hip Fractures
- Surgical Blood Loss

## Interventions

- **DRUG:** Tranexamic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02580227
- **Lead sponsor:** Good Samaritan Regional Medical Center, Oregon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2016-08
- **Final completion:** 2017-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02580227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02580227, "Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02580227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*